{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:02:38Z","timestamp":1790697758600,"version":"4.1.0"},"reference-count":35,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"unspecified","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"GSK-GlaxoSmithKline Espa\u00f1a","award":["ID 213480"],"award-info":[{"award-number":["ID 213480"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2026,6,12]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the dynamics of C3, C4 and anti-dsDNA antibody levels and their association with clinical activity and flares in patients with systemic lupus erythematosus (SLE) treated with belimumab (BEL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective longitudinal cohort study from the BELILES-GEAS registry. Serological markers were assessed at the time of SLE diagnosis, at baseline, at each follow-up visit (months 3, 6, 12, 18, and 24 after treatment initiation) and during disease flares.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 371 patients were included, with a median drug exposure of 13.2 months. At baseline, 70.1% of patients were seropositive. SLE Disease Activity Index 2000 (SLEDAI-2K) and cSLEDAI scores and prednisone doses decreased significantly over time, whereas serum C3 and C4 levels, anti-dsDNA positivity and immunosuppressant use remained stable. Among 95 (25.6%) patients who experienced 139 (14.5%) flares, longitudinal analysis adjusted by immunosuppressant use and prednisone dose revealed no association between flare occurrence and low C3 or C4, whereas anti-dsDNA antibody positivity was (C3 OR=1.31, 95%\u2009CI 0.82 to 2.09; C4 OR=1.08, 95%\u2009CI 0.62 to 1.86, and anti-dsDNA OR=1.81, 95%\u2009CI 1.09 to 3.01, respectively). When stratified by flare severity, low C3 levels showed a borderline association with moderate-to-severe flares (OR=1.82, 95%\u2009CI 0.99 to 3.31), while no significant associations were observed for C4 or for mild flares. There was no association between serum level of C3 or C4 and cSLEDAI. The flare-discriminative performance of SLEDAI-2K and cSLEDAI was similar (AUC-ROCs 0.779 vs 0.781, p=0.88).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In SLE patients treated with BEL, the clinical utility of serological markers appears dissociated from disease activity. While C3 and C4 levels were not clearly related to disease activity or flares, low C3 levels showed a borderline association with moderate-to-severe flares, and anti-dsDNA positivity remained associated with increased flare risk, supporting a clinical assessment\u2013driven approach with complementary use of anti-dsDNA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/lupus-2026-001980","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:50:18Z","timestamp":1784555418000},"page":"e001980","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of belimumab on the utility of serological markers for assessing systemic lupus erythematosus activity"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9798-4514","authenticated-orcid":false,"given":"V\u00edctor","family":"Moreno-Torres","sequence":"first","affiliation":[{"name":"Internal Medicine, Puerta de Hierro University Hospital of Majadahonda, Majadahonda, Spain"},{"name":"Health Sciences School & Medical Center, UNIR, Logro\u00f1o, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Royuela","sequence":"additional","affiliation":[{"name":"Biostatistics Unit, Fundaci\u00f3n para la Investigaci\u00f3n Biom\u00e9dica del Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5404-4944","authenticated-orcid":false,"given":"Guillem","family":"Policarpo-Torres","sequence":"additional","affiliation":[{"name":"Internal Medicine, Girona Clinic, Girona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8378-8638","authenticated-orcid":false,"given":"Diana","family":"Paredes Ruiz","sequence":"additional","affiliation":[{"name":"Internal Medicine, Cruces University Hospital, Barakaldo, Spain"},{"name":"Autoimmune Diseases Research Unit, Instituto de Investigaci\u00f3n Sanitaria Biobizkaia, Barakaldo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Calabuig","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital La Fe, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"S\u00e1nchez Bern\u00e1","sequence":"additional","affiliation":[{"name":"Unidad de Enfermedades Autoinmunes Sist\u00e9micas. Servicio de Medicina Interna, Hospital Universitario Virgen de las Nieves, Granada, Spain"},{"name":"MP03-Medicina Interna-HVN Investiga, Instituto de Investigaci\u00f3n Biosanitaria de Granada, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5517-7482","authenticated-orcid":false,"given":"Olga","family":"Capdevila Pons","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Universitari de Bellvitge, L\u2019Hospitalet de Llobregat, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"August\u00edn","family":"Colodro","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Universitario de Ja\u00e9n, Ja\u00e9n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Salvador","family":"Garc\u00eda-Morillo","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Universitario Virgen del Roc\u00edo, Seville, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Pallar\u00e9s","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Universitari Son Espases, Palma de Mallorca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Trapiella","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela","family":"Marin Ballv\u00e9","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednico Universitario Lozano Blesa, Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Lavilla-Olleros","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Callejas-Rubio","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Universitario San Cecilio, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Tornero","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Parra","sequence":"additional","affiliation":[{"name":"Hospital Universitario Sant Joan de Reus, Reus, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-6396","authenticated-orcid":false,"given":"Ignasi","family":"Rodr\u00edguez-Pint\u00f3","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital de Terrassa, Terrassa, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Barbado Ajo","sequence":"additional","affiliation":[{"name":"Internal Medicine, Rio Hortega University Hospital, Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael","family":"Calero-Paniagua","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Virgen de la Luz, Cuenca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Rubio","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Universitario Nuestra Se\u00f1ora de la Candelaria, Santa Cruz de Tenerife, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Argibay","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital \u00c1lvaro Cunqueiro, Vigo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M","family":"G\u00f3mez-Verd\u00fa","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital General Universitario Jos\u00e9 M Morales Meseguer, Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Miguel","family":"L\u00f3pez-Dupla","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Jorge","family":"Ripper","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1156-2570","authenticated-orcid":false,"given":"Angel","family":"Robles-Marhuenda","sequence":"additional","affiliation":[{"name":"Internal Medicine, La Paz University Hospital, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Calvo-Begueria","sequence":"additional","affiliation":[{"name":"Internal Medicine, San Jorge University General Hospital of Huesca, Huesca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Universitario de Cabue\u00f1es, Gijon, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Gonz\u00e1lez-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Universitario Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kima","family":"L\u00f3pez-Aldabe","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital de Galdakao-Usansolo, Galdakao, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Frutos- P\u00e9rez","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital de Fuenlabrada, Fuenlabrada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hurtado-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Vega Baja, San Bartolom\u00e9, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ponce","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital de Viladecans, Viladecans, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Artinyan","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Universitario Infanta Leonor, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5257-1150","authenticated-orcid":false,"given":"Angel Pedro","family":"Crisolino Pozas","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Universitario de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja","family":"De Miguel-Campo","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Pousibet","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital de Poniente de Almer\u00eda, El Ejido, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1336-0163","authenticated-orcid":false,"given":"Gerard","family":"Espinosa","sequence":"additional","affiliation":[{"name":"Autoimmune Diseases, Hospital Clinic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"2026092908101590000_13.2.e001980.1","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2026092908101590000_13.2.e001980.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.2315"},{"key":"2026092908101590000_13.2.e001980.3","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/cts.13283","article-title":"Serum cytokines to predict systemic lupus erythematosus clinical and serological activity","volume":"15","author":"Moreno-Torres","year":"2022","journal-title":"Clin Transl Sci"},{"key":"2026092908101590000_13.2.e001980.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00739-3"},{"key":"2026092908101590000_13.2.e001980.5","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-025-02168-0","article-title":"Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics","volume":"10","author":"Dai","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"2026092908101590000_13.2.e001980.6","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"2026092908101590000_13.2.e001980.7","first-page":"S37","article-title":"Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics\/American College of Rheumatology Damage Index (SDI)","volume":"63 Suppl 11","author":"Romero-Diaz","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026092908101590000_13.2.e001980.8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/oxfordjournals.qjmed.a068841","article-title":"The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus","volume":"86","author":"Hay","year":"1993","journal-title":"Q J Med"},{"key":"2026092908101590000_13.2.e001980.9","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000538","article-title":"2021 DORIS definition of remission in SLE: final recommendations from an international task force","volume":"8","author":"van Vollenhoven","year":"2021","journal-title":"Lupus Sci Med"},{"key":"2026092908101590000_13.2.e001980.10","doi-asserted-by":"crossref","unstructured":"Fanouriakis A , Kostopoulou M , Andersen J , et al . EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 2023. doi:10.1136\/ard-2024-225617","DOI":"10.1136\/ard-2024-225617"},{"key":"2026092908101590000_13.2.e001980.11","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2025-0390.O016"},{"key":"2026092908101590000_13.2.e001980.12","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1093\/rheumatology\/keaf107","article-title":"Treat-to-target in SLE: is serology important? Results from an integrated analysis of five randomized clinical trials of belimumab","volume":"64","author":"Gomez","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026092908101590000_13.2.e001980.13","doi-asserted-by":"publisher","DOI":"10.1002\/art.34400"},{"key":"2026092908101590000_13.2.e001980.14","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa403"},{"key":"2026092908101590000_13.2.e001980.15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.rceng.2023.11.001","article-title":"Treatment of systemic lupus erythematosus: new therapeutic options","volume":"223","author":"Gonz\u00e1lez-Garc\u00eda","year":"2023","journal-title":"Revista Cl\u00ednica Espa\u00f1ola (English Edition)"},{"key":"2026092908101590000_13.2.e001980.16","doi-asserted-by":"publisher","DOI":"10.1002\/art.30613"},{"key":"2026092908101590000_13.2.e001980.17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"The Lancet"},{"key":"2026092908101590000_13.2.e001980.18","article-title":"Belimumab for systemic lupus erythematosus","volume":"2","author":"Singh","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2026092908101590000_13.2.e001980.19","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-025-03581-0","article-title":"Enhancing systemic lupus erythematosus treatment outcomes with an early initiation of belimumab: insights from a multicenter retrospective study within the first five years","volume":"27","author":"Kojima","year":"2025","journal-title":"Arthritis Res Ther"},{"key":"2026092908101590000_13.2.e001980.20","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2215\/CJN.02520322","article-title":"Safety and Efficacy of Belimumab in Patients with Lupus Nephritis","volume":"17","author":"Furie","year":"2022","journal-title":"CJASN"},{"key":"2026092908101590000_13.2.e001980.21","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/acr.24901","article-title":"Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus","volume":"74","author":"Urowitz","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026092908101590000_13.2.e001980.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001180"},{"key":"2026092908101590000_13.2.e001980.23","doi-asserted-by":"crossref","unstructured":"Wang J , Ju B , Zhu L , et al . The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients. Front Pharmacol 2023;14. doi:10.3389\/fphar.2023.1080730","DOI":"10.3389\/fphar.2023.1080730"},{"key":"2026092908101590000_13.2.e001980.24","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200937"},{"key":"2026092908101590000_13.2.e001980.25","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2026092908101590000_13.2.e001980.26","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390303"},{"key":"2026092908101590000_13.2.e001980.27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sj\u00f6gren\u2019s Syndrome: A Consensus and Data\u2010Driven Methodology Involving Three International Patient Cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2026092908101590000_13.2.e001980.28","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224609"},{"key":"2026092908101590000_13.2.e001980.29","doi-asserted-by":"crossref","unstructured":"Hosmer DW , Lemeshow S . Applied logistic regression. 2nd edn. 2000.","DOI":"10.1002\/0471722146"},{"key":"2026092908101590000_13.2.e001980.30","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-13-92","article-title":"A tutorial on sensitivity analyses in clinical trials: the what, why, when and how","volume":"13","author":"Thabane","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"2026092908101590000_13.2.e001980.31","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1093\/rheumatology\/keaf332","article-title":"Lupus serology: off target but still relevant to the treat-to-target strategy in systemic lupus erythematosus","volume":"64","author":"Piga","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026092908101590000_13.2.e001980.32","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/rheumatology\/keae023","article-title":"Predictors of renal flares in systemic lupus erythematosus: a post-hoc analysis of four phase III clinical trials of belimumab","volume":"64","author":"J\u00e4gerback","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026092908101590000_13.2.e001980.33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/09612033221074580","article-title":"The association between lupus serology and disease outcomes: A systematic literature review to inform the treat-to-target approach in systemic lupus erythematosus","volume":"31","author":"Kostopoulou","year":"2022","journal-title":"Lupus"},{"key":"2026092908101590000_13.2.e001980.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.02.014"},{"key":"2026092908101590000_13.2.e001980.35","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1177\/09612033211014272","article-title":"Combining maintenance therapy with hydroxychloroquine increases LLDAS achievement rates in individuals with stable systemic lupus erythematosus","volume":"30","author":"Yoshida","year":"2021","journal-title":"Lupus"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2026-001980","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:14:47Z","timestamp":1790694887000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2026-001980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,7,20]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/lupus-2026-001980"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2026-001980","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}